# Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing

> **NCT04684121** · PHASE2 · WITHDRAWN · sponsor: **Xequel Bio, Inc.**

## Conditions studied

- Second Degree Burn
- Thermal Burn

## Interventions

- **DRUG:** Granexin® gel (200 μM)
- **DRUG:** Vehicle gel

## Key facts

- **NCT ID:** NCT04684121
- **Lead sponsor:** Xequel Bio, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No longer aligned with company strategy
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684121, "Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04684121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*